Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03807856 · ClinicalTrials.gov registry record · Phase 1
Treating Acute Pancreatitis With Dabigatran, a Pilot Study
A Phase 1 study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT03807856: Clinical Trial Phase 1 study, sponsored by Mayo Clinic.
NCT03807856 is a Phase 1 study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03807856, a Phase 1 study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
Researchers are studying the safety and efficacy of Dabigatran in the treatment of acute pancreatitis.
Interventions
- OTHER Standard of Care
- DRUG Dabigatran Etexilate Mesylate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2019-06-24 |
| Est. Completion | 2020-07-23 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03807856
The ClinicalTrials.gov registry entry for NCT03807856 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT03807856 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03807856 about?
NCT03807856 is a clinical study titled "Treating Acute Pancreatitis With Dabigatran, a Pilot Study". Researchers are studying the safety and efficacy of Dabigatran in the treatment of acute pancreatitis.
What is the current status of trial NCT03807856?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2019-06-24. Estimated completion is 2020-07-23.
What interventions are being tested in trial NCT03807856?
The interventions under investigation include: Standard of Care (OTHER), Dabigatran Etexilate Mesylate (DRUG).
Who is sponsoring clinical trial NCT03807856?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.